Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo
Next-generation lipid nanoparticles that target non-hepatocytes could be important clinical tools. Using in vivo DNA barcoding, the authors identify piperazine-containing lipids deliver mRNA to immune cells without targeting ligands.
Main Authors: | Huanzhen Ni, Marine Z. C. Hatit, Kun Zhao, David Loughrey, Melissa P. Lokugamage, Hannah E. Peck, Ada Del Cid, Abinaya Muralidharan, YongTae Kim, Philip J. Santangelo, James E. Dahlman |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-08-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-022-32281-5 |
Similar Items
-
Nanoparticles containing constrained phospholipids deliver mRNA to liver immune cells in vivo without targeting ligands
by: Zubao Gan, et al.
Published: (2020-09-01) -
Crosslinking in the diglycidyl ether oligoepichlorhydrin-piperazine
by: Konstantyn E. Varlan, et al.
Published: (2014-03-01) -
4-(Methylsulfonyl)piperazin-1-ium chloride
by: Hoong-Kun Fun, et al.
Published: (2010-02-01) -
Ethyl 4-(phenylsulfonyl)piperazine-1-carboxylate
by: Mohammad T.M. Al-Dajani, et al.
Published: (2011-09-01) -
A systematic analysis of biotech startups that went public in the first half of 2021
by: Sebastian G. Huayamares, et al.
Published: (2022-01-01)